Cargando…

Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years

BACKGROUND: Intrahepatic sarcomatoid chonalgiocarcinoma (s-CCC) is an extremely rare disease, accounting for less than 1% of hepatobiliary system malignancies, and its pathophysiology is not well known. On the hypothesis that its clinical, serologic, or radiologic diagnosis are not fully understood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Kyun, Kim, Bo Ra, Jeong, Jin Sook, Baek, Yang Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371010/ https://www.ncbi.nlm.nih.gov/pubmed/30774275 http://dx.doi.org/10.3748/wjg.v25.i5.608

Ejemplares similares

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
por: Yuan, Zi-Bo, et al.
Publicado: (2022)

An extremely rare case of intrahepatic sarcomatoid cholangiocarcinoma
por: Lieu, Dau Quang, et al.
Publicado: (2023)

Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection
por: Li, Hui, et al.
Publicado: (2020)

Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
por: Huang, Jia-Yan, et al.
Publicado: (2020)

Huge subcapsular hematoma caused by intrahepatic sarcomatoid cholangiocarcinoma
por: Jung, Gum O, et al.
Publicado: (2012)

Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients
por: Feng, Jian, et al.
Publicado: (2022)

Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection
por: Deng, Li-Ming, et al.
Publicado: (2021)

Histopathological characteristics of needle core biopsy and surgical specimens from patients with solitary hepatocellular carcinoma or intrahepatic cholangiocarcinoma
por: Wu, Ju-Shan, et al.
Publicado: (2019)

Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection
por: Wang, Jin-Ju, et al.
Publicado: (2020)

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
por: Chen, Li-Da, et al.
Publicado: (2018)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Sarcomatoid Intrahepatic Cholangiocarcinoma: A Rare and Aggressive Primary Liver Cancer
por: Zaher, Eli A, et al.
Publicado: (2023)

Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma
por: Sempokuya, Tomoki, et al.
Publicado: (2020)

Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature
por: Zeng, Zheng, et al.
Publicado: (2022)

Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017)

Focal intrahepatic strictures: A proposal classification based on diagnosis-treatment experience and systemic review
por: Zhou, Di, et al.
Publicado: (2020)

MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Zhang, Hongbin, et al.
Publicado: (2021)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience
por: Li, Cheng-Gang, et al.
Publicado: (2020)

Significance of dysplasia in bile duct resection margin in patients with extrahepatic cholangiocarcinoma: A retrospective analysis
por: Choe, Jung Wan, et al.
Publicado: (2022)

Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
por: Li, Xu, et al.
Publicado: (2020)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Intrahepatic sarcomatoid cholangiocarcinoma: A case report of the youngest patient on record and a review of the condition's characteristics
por: Xi, Long-Fu, et al.
Publicado: (2022)

Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
por: Duong, Nikki, et al.
Publicado: (2022)

Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt
por: Bucher, Julian Nikolaus, et al.
Publicado: (2019)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

Macro- and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia
por: Schelker, Roland C, et al.
Publicado: (2017)

Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome
por: Zhou, Chun-Ze, et al.
Publicado: (2020)

Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma
por: Shiraki, Takayuki, et al.
Publicado: (2018)

Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas
por: Lin, Hua-Peng, et al.
Publicado: (2018)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
por: Hsu, Michael C, et al.
Publicado: (2017)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma
por: Tang, You-Yin, et al.
Publicado: (2021)

Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma
por: Li, Yuan-Ming, et al.
Publicado: (2022)

CT and MRI findings of sarcomatoid cholangiocarcinoma
por: Bilgin, Mehmet, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gkoc92j8earrkpei9sv64d8p5o